Spots Global Cancer Trial Database for nasopharynx or paranasal sinuses that is considered appropriate
Every month we try and update this database with for nasopharynx or paranasal sinuses that is considered appropriate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
MLN8237 in Head and Neck Cancer | NCT01540682 | Head and Neck C... | MLN8237 Cetuximab Radiotherapy | 18 Years - | Abramson Cancer Center at Penn Medicine |